قالب وردپرس درنا توس
Home / Technology / Startup claims its new wearable device can monitor blood sugar without needles

Startup claims its new wearable device can monitor blood sugar without needles



Quality assurance

Quantum Computing Corporation

Compared with the commercial pointing display FreeStyle Libre, Quantum Operation provides its data sampling. Moreover, at this point, there is indeed a clear difference between wearable devices and Libre. Currently, this may be a deal for those who rely on accurate blood glucose readings to determine their insulin dose.

Non-invasive blood glucose monitoring is the holy grail of the medical industry and major wearable brands. After all, one in ten Americans suffers from diabetes, and as the obesity crisis continues to intensify, this number may rise. In order to stay healthy, today̵

7;s diabetic patients need to regularly perform finger prick tests or wear implantable blood glucose monitors. In the past five years, companies like Dexcom and Abbott have even found ways to connect these displays to smart watches for easy tracking.

Naturally, the wearable industry is always looking for a simpler and less invasive way to try to steal some lunch. Unfortunately, no company can successfully demonstrate an effective version of the technology, at least not up to commercial standards. In 2017, a company called PKVitality came to CES with a watch. The back of the watch has a series of 0.5 mm high needles that can collect tissue fluid from the skin. But this is hardly noninvasive.

According to reports, even before Jobs died, Apple had been working on the blood glucose monitoring platform. In 2017, there were rumors that the company had a dedicated laboratory to study methods of monitoring blood sugar through wearable devices.In 2018 Apple Insider It was discovered that the company had applied for a patent related to the use of absorption spectroscopy to monitor blood glucose levels.

This secret team is apparently supported by former employees of C8 MediSensors, which failed to complete this task at the beginning of the past decade. It raised $60 million in investment from companies such as General Electric (GE), but failed to create an effective product before it closed in early 2013. MIT Technology Review According to the company’s data starting in 2014, C8 can’t solve the variability problem at all-readings vary from person to person-before the money runs out.

In the above examples and other projects, a technique called Raman spectroscopy has seen some hope. In 2018, a team of researchers from the University of Missouri and the Massachusetts Institute of Technology discovered that when a laser beam is pressed on the wrist, a laser can be used to monitor glucose through a fiber optic cable. At the time, the researchers stated that the system could provide readings comparable to pointing tests.

Before we can see this technology in work products, there is still a long way to go, even longer than the technology we want to buy. However, if Quantum can prove that it avoids the pitfalls encountered by some competitors and that its technology is sufficiently accurate, then this could be very exciting.

Of course, this is an all-virtual CES, and it is even harder to treat the company’s wonderful propositions as real objects. If we participate in the exhibition in person, we will be able to test the equipment in person and communicate with the founder face to face. It is also worth noting that there is currently no peer-reviewed or otherwise externally validated science to support this particular technology and its applications. We can’t make any serious judgments about this technology. We can only say that if Quantum Operation can fulfill its requirements, then we may be in an exciting time for wearable devices.


Source link